EasySep™小鼠TIL（CD45）正选试剂盒
产品号 #05008_C
无血清和无bpe培养基用于原代人气道上皮细胞的扩增
若您需要咨询产品或有任何技术问题，请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系
Interested in trying STEMCELL's products for respiratory research? Fill out this form to request information about introductory offers.
专为您的实验方案打造的产品
要查看实验方案所需的所有配套产品，请参阅《实验方案与技术文档》。
-
Trypsin-EDTA (0.05%)Enzymatic cell dissociation reagent
-
Hydrocortisone Stock SolutionCell culture supplement
-
HBSS, Modified (Without Ca++ and Mg++)Hanks' Balanced Salt Solution (HBSS) without calcium and magnesium
-
D-PBS (Without Ca++ and Mg++)Dulbecco’s phosphate-buffered saline without calcium and magnesium
总览
PneumaCult™- ex是一种明确的，不含血清和bpe的细胞培养基，支持人类气道上皮细胞的快速扩增。
在PneumaCult™-Ex中培养的原代气道上皮细胞在至少3代内迅速扩增，同时保持鹅卵石状形态和基底细胞标记物p63和p75的均匀表达NTR． 此外，在PneumaCult™-Ex中培养的细胞在气液界面中培养时可以分化成假层状粘膜纤毛上皮。
一起，PneumaCult™-Ex和PneumaCult™-ALI构成了一个完全集成的无bpe培养系统，用于体外人体气道建模。这一强大而明确的系统是基础呼吸研究、毒性研究和药物开发的宝贵工具。
了解如何培养人类气道上皮细胞在我们的ALI按需肺课程或浏览我们的常见问题（FAQs）关于使用PneumaCult™的ALI培养工作流程。
Subtype
Specialized Media
Cell Type
Airway Cells
Species
Human
Application
Cell Culture, Expansion, Maintenance
Brand
PneumaCult
Area of Interest
Epithelial Cell Biology
Formulation Category
Serum-Free
实验数据
产品说明书及文档
请在《产品说明书》中查找相关支持信息和使用说明，或浏览下方更多实验方案。
应用领域
本产品专为以下研究领域设计，适用于工作流程中的高亮阶段。探索这些工作流程，了解更多我们为各研究领域提供的其他配套产品。
相关材料与文献
技术资料 (11)
文献 (14)
Impact of KLF4 on Cell Proliferation and Epithelial Differentiation in the Context of Cystic Fibrosis. International journal of molecular sciences 2020 sep
Abstract
Cystic fibrosis (CF) cells display a more cancer-like phenotype vs. non-CF cells. KLF4 overexpression has been described in CF and this transcriptional factor acts as a negative regulator of wt-CFTR. KLF4 is described as exerting its effects in a cell-context-dependent fashion, but it is generally considered a major regulator of proliferation, differentiation, and wound healing, all the processes that are also altered in CF. Therefore, it is relevant to characterize the differential role of KLF4 in these processes in CF vs. non-CF cells. To this end, we used wt- and F508del-CFTR CFBE cells and their respective KLF4 knockout (KO) counterparts to evaluate processes like cell proliferation, polarization, and wound healing, as well as to compare the expression of several epithelial differentiation markers. Our data indicate no major impact of KLF4 KO in proliferation and a differential impact of KLF4 KO in transepithelial electrical resistance (TEER) acquisition and wound healing in wt- vs. F508del-CFTR cells. In parallel, we also observed a differential impact on the levels of some differentiation markers and epithelial-mesencymal transition (EMT)-associated transcription factors. In conclusion, KLF4 impacts TEER acquisition, wound healing, and the expression of differentiation markers in a way that is partially dependent on the CFTR-status of the cell.
Aprotinin Inhibits SARS-CoV-2 Replication. Cells 2020 oct
Abstract
Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is the cause of the current coronavirus disease 19 (COVID-19) pandemic. Protease inhibitors are under consideration as virus entry inhibitors that prevent the cleavage of the coronavirus spike (S) protein by cellular proteases. Herein, we showed that the protease inhibitor aprotinin (but not the protease inhibitor SERPINA1/alpha-1 antitrypsin) inhibited SARS-CoV-2 replication in therapeutically achievable concentrations. An analysis of proteomics and translatome data indicated that SARS-CoV-2 replication is associated with a downregulation of host cell protease inhibitors. Hence, aprotinin may compensate for downregulated host cell proteases during later virus replication cycles. Aprotinin displayed anti-SARS-CoV-2 activity in different cell types (Caco2, Calu-3, and primary bronchial epithelial cell air-liquid interface cultures) and against four virus isolates. In conclusion, therapeutic aprotinin concentrations exert anti-SARS-CoV-2 activity. An approved aprotinin aerosol may have potential for the early local control of SARS-CoV-2 replication and the prevention of COVID-19 progression to a severe, systemic disease.
Loss of versican and production of hyaluronan in lung epithelial cells are associated with airway inflammation during RSV infection. The Journal of biological chemistry 2020 nov
Abstract
Airway inflammation is a critical feature of lower respiratory tract infections caused by viruses such as respiratory syncytial virus (RSV). A growing body of literature has demonstrated the importance of extracellular matrix (ECM) changes such as the accumulation of hyaluronan (HA) and versican in the subepithelial space in promoting airway inflammation; however, whether these factors contribute to airway inflammation during RSV infection remains unknown. To test the hypothesis that RSV infection promotes inflammation via altered HA and versican production, we studied an ex vivo human bronchial epithelial cell (BEC)/human lung fibroblast (HLF) co-culture model. RSV infection of BEC/HLF co-cultures led to decreased hyaluronidase expression by HLFs, increased accumulation of HA, and enhanced adhesion of U937 cells as would be expected with increased HA. HLF production of versican was not altered following RSV infection; however, BEC production of versican was significantly downregulated following RSV infection. In vivo studies with epithelial-specific versican-deficient mice [SPC-Cre(+) Vcan-/-] demonstrated that RSV infection led to increased HA accumulation compared to control mice which also coincided with decreased hyaluronidase expression in the lung. SPC-Cre(+) Vcan-/- mice demonstrated enhanced recruitment of monocytes and neutrophils in bronchoalveolar lavage fluid and increased neutrophils in the lung compared to SPC-Cre(-) RSV-infected littermates. Taken together, these data demonstrate that altered ECM accumulation of HA occurs following RSV infection and may contribute to airway inflammation. Additionally, loss of epithelial expression of versican promotes airway inflammation during RSV infection further demonstrating that versican's role in inflammatory regulation is complex and dependent on the microenvironment.
更多信息
| 种属 | Human |
|---|---|
| 配方类别 | Serum-Free |
相关产品
-
PneumaCult™阿里介质在气液界面培养的人气道上皮细胞的无血清和无bpe培养基
-
PneumaCult™-Ex Plus Medium无血清和无bpe培养基用于原代人气道上皮细胞的扩增
-
台盼蓝哺乳动物活细胞计数试剂
